KK
OKUR

Kotler Kevin’s OnKure Therapeutics OKUR Stock Holding History

Kotler Kevin’s Portfolio OKUR Stock Details OKUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$573K Buy
+197,691
New +$592K 0.13% 27

Other funds holding OKUR

ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
SC
Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HCM
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
SG
StepStone Group La Jolla, California $2.16B AUM 20.11% 1-Year Est. Return

Kotler Kevin's OKUR Position: Q4 2025 in Review

Kotler Kevin opened a new position in OnKure Therapeutics (OKUR) in Q4 2025: 197,691 shares worth $573K. The stake represents 0.13% of the portfolio and ranks #27 among its holdings.

44 funds tracked by Wall St. Rank hold OKUR as of Q4 2025.

  • Kotler Kevin held 197,691 shares of OnKure Therapeutics worth $573K as of Q4 2025.
  • OnKure Therapeutics was a new Kotler Kevin position in Q4 2025.
  • OnKure Therapeutics made up 0.13% of Kotler Kevin's portfolio in Q4 2025, its #27 holding.
  • 44 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q4 2025.

Based on Kotler Kevin's 13F filing for Q4 2025, filed 17 Feb 2026.